Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 16/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 9/20 | 0.53 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.42 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.42 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.39 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL760692 | 0.80 | ESR1 (0.60) | ESR1ESR2HSD17B1HSD17B2FGFR1 | |
| SCHEMBL7913380 | 0.80 | KIF11 (0.66) | ESR1ESR2KIF11HSD17B1HSD17B2 | |
| SCHEMBL3440740 | 0.80 | ESR1 (0.60) | ESR1ESR2HSD17B1HSD17B2FGFR1 | |
| SCHEMBL12917874 | 0.79 | KIF11 (0.69) | ESR1ESR2KIF11HSD17B1HSD17B2 | |
| SCHEMBL13002564 | 0.78 | PDE3B (0.38) | ALOX5APFEN1 | |
| SCHEMBL22440624 | 0.78 | ALOX5AP (0.44) | KIF11ALOX5APFEN1 | |
| SCHEMBL30509766 | 0.78 | ALOX5AP (0.44) | KIF11ALOX5APFEN1 | |
| SCHEMBL759007 | 0.77 | CA12 (0.41) | ESR1ESR2KIF11 | |
| SCHEMBL14241280 | 0.77 | ESR1 (0.45) | ESR1ESR2HSD17B1HSD17B2FGFR1 | |
| SCHEMBL1815385 | 0.77 | ESR1 (0.67) | ESR1ESR2HSD17B1HSD17B2FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2904068-B1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2016-10-12 | — | — | EP | disclosed |
| US-9441161-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-09-13 | — | — | US | disclosed |
| US-9441161-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-09-13 | — | — | US | disclosed |
| US-20160032187-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20160032187-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2016-02-04 | — | — | US | disclosed |
| US-8974694-B2 | Liquid-crystal composition | JNC CORPORATION (JP) | 2015-03-10 | — | — | US | disclosed |
| US-8974694-B2 | Liquid-crystal composition | JNC CORPORATION (JP) | 2015-03-10 | — | — | US | disclosed |
| EP-2568032-B1 | Liquid crystal medium and liquid crystal display | MERCK PATENT GMBH (DE) | 2014-11-26 | — | — | EP | disclosed |
| US-8586803-B2 | Chlorofluorobenzene compound, optically isotropic liquid crystal medium and optical device | JNC CORPORATION (JP) | 2013-11-19 | — | — | US | disclosed |
| US-20130188107-A1 | LIQUID-CRYSTAL COMPOSITION | JNC PETROCHEMICAL CORPORATION (JP) | 2013-07-25 | — | — | US | disclosed |
| US-20130188107-A1 | LIQUID-CRYSTAL COMPOSITION | JNC PETROCHEMICAL CORPORATION (JP) | 2013-07-25 | — | — | US | disclosed |
| EP-2586764-A1 | COMPOUND HAVING BRANCHED ALKYL OR BRANCHED ALKENYL, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL ELEMENT | JNC Corporation (JP) | 2013-05-01 | — | — | EP | disclosed |
| US-20130100369-A1 | COMPOUND HAVING BRANCHED ALKYL OR BRANCHED ALKENYL, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL ELEMENT | JNC PETROCHEMICAL CORPORATION (JP) | 2013-04-25 | — | — | US | disclosed |
| US-20130100369-A1 | COMPOUND HAVING BRANCHED ALKYL OR BRANCHED ALKENYL, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL ELEMENT | JNC PETROCHEMICAL CORPORATION (JP) | 2013-04-25 | — | — | US | disclosed |
| US-20130085306-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | HASEBA YASUHIRO (JP) | 2013-04-04 | — | — | US | disclosed |
| US-20130085306-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | HASEBA YASUHIRO (JP) | 2013-04-04 | — | — | US | disclosed |
| EP-2568032-A2 | Liquid crystal medium and liquid crystal display | Merck Patent GmbH (DE) | 2013-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085306-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | DDT, BRAF, CFAP410 | ESR1 3892/4885ESR2 3716/4885KIF11 33/4885 |
| US-20160032187-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | OCIAD1, OCIAD2, PIEZO1 | ESR1 3217/4885ESR2 3712/4885KIF11 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.